A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Journal of Clinical Epidemiology

Volumn 62, Issue 5, 2009, Pages 464-475

  Thorpe, Kevin E ^a   Zwarenstein, Merrick ^b   Oxman, Andrew D ^c   Treweek, Shaun ^d   Furberg, Curt D ^e   Altman, Douglas G ^f   Tunis, Sean ^g   Bergel, Eduardo ^h   Harvey, Ian ⁱ   Magid, David J ^j   Chalkidou, Kalipso ^k  

^a UNIVERSITY OF TORONTO   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g Center for Medical Technology Policy   (United States)

^h WORLD BANK   (United States)

ⁱ UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^j KAISER PERMANENTE   (United States)

^k NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

more..

Author keywords

Clinical trial; Clinical trial methodology; Explanatory trial; Pragmatic trial; Randomized controlled trials; Trial design

Indexed keywords

ARTICLE; DECISION MAKING; HEALTH CARE FINANCING; MEDICAL RESEARCH; METHODOLOGY; PATIENT CARE; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; CONSENSUS; DECISION MAKING; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 63449090101     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.12.011     Document Type: Article

References (13)

1. Schwartz D., and Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20 (1967) 637-648 [reprinted in this issue; J Clin Epidemiol 2009;62:498-504]
2. Sackett D.L. Explanatory vs. management trials. In: Haynes R.B., Sackett D.L., Guyatt G.H., and Tugwell P. (Eds). Clinical epidemiology: how to do clinical practice research (2006), Lippincott, Williams and Wilkins, Philadelphia
3. Gartlehner G., Hansen R.A., Nissman D., Lohr K.N., and Carey T.S. A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol 59 (2006) 1040-1048
4. Zwarenstein M, Treweek S, Gagnier J, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
5. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 290 (2003) 1624-1632
6. Tunis S.R. A clinical research strategy to support shared decision making. Health Aff 24 (2005) 180-184
7. Pragmatic Randomized Controlled Trials in HealthCare. http://www.practihc.org/
8. Scheel I.B., Hagen K.B., Herrin J., Carling C., and Oxman A.D. Blind faith? The effects of promoting active sick leave for back pain patients. A cluster-randomized trial. Spine 27 (2002) 2734-2740
9. Zwarenstein M., Schoeman J.H., Vundule C., Lombard C.J., and Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352 (1998) 1340-1343
10. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
11. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 (1994) 619-629
12. Caritis S., Sibai B., Hauth J., Lindheimer M.D., Klebanoff M., Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 338 (1998) 701-705
13. Rothwell P.M. External validity of randomised controlled trials: "to whom do the results of this trial apply?. Lancet 365 (2005) 82-93